CN116585389A - 一种治疗湿疹的中药组合物及其制备方法 - Google Patents
一种治疗湿疹的中药组合物及其制备方法 Download PDFInfo
- Publication number
- CN116585389A CN116585389A CN202310349615.4A CN202310349615A CN116585389A CN 116585389 A CN116585389 A CN 116585389A CN 202310349615 A CN202310349615 A CN 202310349615A CN 116585389 A CN116585389 A CN 116585389A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- medicine composition
- eczema
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 201000004624 Dermatitis Diseases 0.000 title claims abstract description 72
- 208000010668 atopic eczema Diseases 0.000 title claims abstract description 72
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title abstract description 12
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 10
- 241001071795 Gentiana Species 0.000 claims abstract description 10
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 10
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 10
- 241000405414 Rehmannia Species 0.000 claims abstract description 10
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 9
- 235000008078 Arctium minus Nutrition 0.000 claims abstract description 9
- 244000183685 Citrus aurantium Species 0.000 claims abstract description 9
- 235000007716 Citrus aurantium Nutrition 0.000 claims abstract description 9
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 9
- 241000893536 Epimedium Species 0.000 claims abstract description 9
- 235000018905 epimedium Nutrition 0.000 claims abstract description 9
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 9
- 235000011477 liquorice Nutrition 0.000 claims abstract description 9
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 8
- 240000005001 Paeonia suffruticosa Species 0.000 claims abstract description 6
- 235000003889 Paeonia suffruticosa Nutrition 0.000 claims abstract description 6
- 240000005528 Arctium lappa Species 0.000 claims abstract 2
- 239000000706 filtrate Substances 0.000 claims description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- 238000002156 mixing Methods 0.000 claims description 30
- 239000000463 material Substances 0.000 claims description 25
- 238000001914 filtration Methods 0.000 claims description 18
- 238000000034 method Methods 0.000 claims description 12
- 238000002386 leaching Methods 0.000 claims description 9
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 claims description 4
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 239000008280 blood Substances 0.000 abstract description 14
- 210000004369 blood Anatomy 0.000 abstract description 14
- 208000024891 symptom Diseases 0.000 abstract description 7
- 210000004185 liver Anatomy 0.000 abstract description 6
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 238000009825 accumulation Methods 0.000 abstract description 2
- 230000035790 physiological processes and functions Effects 0.000 abstract description 2
- 239000002574 poison Substances 0.000 abstract description 2
- 231100000614 poison Toxicity 0.000 abstract description 2
- 230000000694 effects Effects 0.000 description 14
- 241000208843 Arctium Species 0.000 description 7
- 208000003251 Pruritus Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000007803 itching Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 241000212322 Levisticum officinale Species 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 239000001645 levisticum officinale Substances 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000125175 Angelica Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000218202 Coptis Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000005373 Dyshidrotic Eczema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- MJJALKDDGIKVBE-UHFFFAOYSA-N ebastine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(=O)CCCN1CCC(OC(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 MJJALKDDGIKVBE-UHFFFAOYSA-N 0.000 description 1
- 229960001971 ebastine Drugs 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 208000030212 nutrition disease Diseases 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 201000011414 pompholyx Diseases 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
- A61K36/296—Epimedium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药组合物技术领域,尤其涉及一种治疗湿疹的中药组合物及其制备方法。本发明提供了一种治疗湿疹的中药组合物,由包括如下质量份数的组分制备而成:当归10~14份、川芎10~14份、黄连8~12份、地黄7~11份、牛蒡子6~10份、仙灵脾6~10份、龙胆草5~9份、枳实5~9份、牡丹皮4~8份和甘草4~8份。本发明所述组合物可清除肝胆湿热,调节气滞血瘀,用于多种类型的湿疹治疗,并且,本发明所述组合物符合中医药理论,用于治疗湿疹的湿热蕴肤证,不仅能迅速消除湿疹的症状,还能通过调节人体生理机能,清除血毒,达到标本兼治目的,有效防止湿疹复发。
Description
技术领域
本发明涉及中药组合物技术领域,尤其涉及一种治疗湿疹的中药组合物及其制备方法。
背景技术
湿疹(eczema)是一种慢性皮肤病,皮疹呈多形性,对称分布,明显瘙痒,慢性病程,影响患者的生活质量。患者常合并过敏性鼻炎、哮喘等疾病,家族成员中也经常有类似过敏性疾病的患者。
湿疹根据病程可以分为急性湿疹、亚急性湿疹、慢性湿疹。根据发病部位可以分为耳部湿疹、手部湿疹、外阴湿疹、阴囊湿疹和肛门湿疹等。另外还包括特殊类型的湿疹,如汗疱疹、自体敏感性湿疹。机体内因包括免疫功能异常和系统性疾病(如内分泌疾病、营养障碍、性感染等)以及遗传性或获得性皮肤屏障功能障碍。外因主要包括环境或食品中的过敏原、刺激原、微生物、环境温度等,这些均可以引发或加重湿疹。
湿疹的中药治疗,分为口服药和外用药的治疗,口服药需要根据湿疹的辨证论治进行分析。在医生的指导下很容易进行治疗,但是湿疹是极易复发的,主要是因为湿疹患者大多皮肤敏感,容易过敏,引起湿疹的复发。
因此,如何提供一种有效治疗湿疹,且治疗后不易复发的中药组合物,是本领域技术人员亟需解决的问题。
发明内容
本发明的目的在于提供种治疗湿疹的中药组合物及其制备方法,解决现有技术当中湿疹容易复发的技术问题。
为了实现上述发明目的,本发明提供以下技术方案:
本发明提供了一种治疗湿疹的中药组合物,由包括如下质量份数的组分制备而成:当归10~14份、川芎10~14份、黄连8~12份、地黄7~11份、牛蒡子6~10份、仙灵脾6~10份、龙胆草5~9份、枳实5~9份、牡丹皮4~8份和甘草4~8份。
本发明还提供了所述的一种治疗湿疹的中药组合物的制备方法,包括如下步骤:
(1)将当归、川芎、黄连、地黄、牛蒡子、仙灵脾、龙胆草、枳实、牡丹皮和甘草混合,粉碎得物料1;
(2)将所述物料1与水混合浸提,过滤得滤液1和滤渣1;
(3)将所述滤渣1与水混合进行一次煎煮,过滤得滤液2和滤渣2;
(4)将所述滤渣2与水混合进行二次煎煮,过滤得滤液3;
(5)将所述滤液1、滤液2和滤液3混合得治疗湿疹的中药组合物。
优选的,步骤(1)所述粉碎后的物料1过40~60目筛,筛下物即为物料1。
优选的,步骤(2)所述浸提的时间为1.5~2.5h。
优选的,步骤(2)所述物料1和水的质量比为1∶3~5。
优选的,步骤(2)所述水的温度为50~60℃。
优选的,步骤(3)所述一次煎煮时间为2~4h。
优选的,步骤(3)所述滤渣1与水的质量比为1∶4~6。
优选的,步骤(4)所述二次煎煮时间为0.5~1.5h。
优选的,步骤(4)所述滤渣2与水的质量比为1∶2~4。
与现有技术相比,本发明具有如下的有益效果:
1、湿疹发生受先天及后天因素影响,内因为饮食不节伤及脾胃,风、湿、热邪入侵以致心、肝、脾、肺等脏腑受累或接触致敏物质所致。治疗以祛风除湿,清热解毒止痒为主,兼润燥。
方中,当归补血活血,止痛润肠;川芎具有活血行气,祛风止痛的功效。当归和川芎合用,可活血;枳实具有破气消积,化痰散痞的功效。牡丹皮具有清热凉血,活血化瘀的功效。上述几种组分合用,活血通气,可有效根治湿疹导致的气滞血瘀。
方中,龙胆具有清热燥湿,泻肝胆火的功效;黄连可清热解毒;地黄具有清热凉血,养阴生津的功能。仙灵脾能补中益气,也能健脾益气,更能燥湿;牛蒡子具有疏散风热,宣肺透疹,解毒利咽的功效。上述几种组分合用,清热解毒、疏风平肝、凉血活血、可有效治疗湿疹带来的肝胆湿热。
甘草具有益气补中,祛痰止咳,解毒,缓急止痛,可以缓和各味药性的功能,调和诸药。
2、本发明所述组合物可清除肝胆湿热,调节气滞血瘀,可用于多种类型的湿疹治疗,并且,本发明所述组合物符合中医药理论,用于治疗湿疹的湿热蕴肤证,不仅能迅速消除湿疹的症状,还能通过调节人体生理机能,清除血毒,达到标本兼治的目的,有效防止湿疹复发。
具体实施方式
本发明提供了一种治疗湿疹的中药组合物,由包括如下质量份数的组分制备而成:当归10~14份、川芎10~14份、黄连8~12份、地黄7~11份、牛蒡子6~10份、仙灵脾6~10份、龙胆草5~9份、枳实5~9份、牡丹皮4~8份和甘草4~8份;优选由包括如下质量份数的组分制备而成:当归11~13份、川芎11~13份、黄连9~11份、地黄8~10份、牛蒡子7~9份、仙灵脾7~9份、龙胆草6~8份、枳实6~8份、牡丹皮5~7份和甘草5~7份;进一步优选由包括如下质量份数的组分制备而成:当归12份、川芎12份、黄连10份、地黄9份、牛蒡子8份、仙灵脾8份、龙胆草7份、枳实7份、牡丹皮6份和甘草6份。
本发明还提供了所述的一种治疗湿疹的中药组合物的制备方法,包括如下步骤:
(1)将当归、川芎、黄连、地黄、牛蒡子、仙灵脾、龙胆草、枳实、牡丹皮和甘草混合,粉碎得物料1;
(2)将所述物料1与水混合浸提,过滤得滤液1和滤渣1;
(3)将所述滤渣1与水混合进行一次煎煮,过滤得滤液2和滤渣2;
(4)将所述滤渣2与水混合进行二次煎煮,过滤得滤液3;
(5)将所述滤液1、滤液2和滤液3混合得治疗湿疹的中药组合物。
在本发明中,步骤(1)所述粉碎后的物料1过40~60目筛,筛下物即为物料1;优选为44~56目;进一步优选为48~52目;更优选为50目。
在本发明中,步骤(2)所述浸提的时间为1.5~2.5h;优选为2h。
在本发明中,步骤(2)所述物料1和水的质量比为1∶3~5;优选为1∶4。
在本发明中,步骤(2)所述水的温度为50~60℃;优选为52~58℃;进一步优选为54~56℃;更优选为55℃。
在本发明中,步骤(3)所述一次煎煮时间为2~4h;优选为3h。
在本发明中,步骤(3)所述滤渣1与水的质量比为1∶4~6;优选为1∶5。
在本发明中,步骤(4)所述二次煎煮时间为0.5~1.5h;优选为1h。
在本发明中,步骤(4)所述滤渣2与水的质量比为1∶2~4;优选为1∶3。
下面结合实施例对本发明提供的技术方案进行详细的说明,但是不能把它们理解为对本发明保护范围的限定。
实施例1
一种治疗湿疹的中药组合物的制备方法,步骤如下:
(1)将当归10份、川芎10份、黄连8份、地黄7份、牛蒡子6份、仙灵脾6份、龙胆草5份、枳实5份、牡丹皮4份和甘草4份混合,粉碎至40目得物料1;
(2)将所述物料1与水温为50℃的水按质量比1∶3混合浸提1.5h,期间水浴保持温度50℃,过滤得滤液1和滤渣1;
(3)将所述滤渣1与水按质量1∶4混合进行煎煮2h,过滤得滤液2和滤渣2;
(4)将所述滤渣2与水按质量比1∶2混合进行煎煮0.5h,过滤得滤液3;
(5)将所述滤液1、滤液2和滤液3混合得治疗湿疹的中药组合物。
实施例2
一种治疗湿疹的中药组合物的制备方法,步骤如下:
(1)将当归14份、川芎14份、黄连12份、地黄11份、牛蒡子10份、仙灵脾10份、龙胆草9份、枳实9份、牡丹皮8份和甘草8份混合,粉碎至60目得物料1;
(2)将所述物料1与水温为60℃的水按质量比1∶5混合浸提2.5h,期间水浴保持温度60℃,过滤得滤液1和滤渣1;
(3)将所述滤渣1与水按质量1∶6混合进行煎煮4h,过滤得滤液2和滤渣2;
(4)将所述滤渣2与水按质量比1∶4混合进行煎煮1.5h,过滤得滤液3;
(5)将所述滤液1、滤液2和滤液3混合得治疗湿疹的中药组合物。
实施例3
一种治疗湿疹的中药组合物的制备方法,步骤如下:
(1)将当归12份、川芎12份、黄连10份、地黄9份、牛蒡子8份、仙灵脾8份、龙胆草7份、枳实7份、牡丹皮6份和甘草6份混合,粉碎至50目得物料1;
(2)将所述物料1与水温为55℃的水按质量比1∶4混合浸提2h,期间水浴保持温度55℃,过滤得滤液1和滤渣1;
(3)将所述滤渣1与水按质量1∶5混合进行煎煮3h,过滤得滤液2和滤渣2;
(4)将所述滤渣2与水按质量比1∶3混合进行煎煮1h,过滤得滤液3;
(5)将所述滤液1、滤液2和滤液3混合得治疗湿疹的中药组合物。
实验例1
按照《中医病证诊断疗效标准94版》记载的急性湿疹诊断标准,选择患有急性湿疹的患者60名,年龄在20~40岁之间。平均分为3组,男女各半。
治疗标准:治愈:症状消失,湿疹消退,无瘙痒感:显效:湿疹消退65%及以上,无瘙痒感;有效:湿疹消退25~65%,稍有瘙痒感;无效:治疗前后无变化,或变化不明显。
以实施例3得到的产品作为实验组;服用方法为:100mL/d/人。
对照组:服用依巴斯汀,按照说明书方法服用。
空白对照组:不做任何处理。
实验为期10d,实验完成后,观察患者的恢复情况,结果如表1所示。在治疗完成后,对实验组和对照组的治愈患者复发情况进行调查,观察患者是否有复发情况,在试验完成后的第3周、第6周和第9周分别进行一次调查,结果如表2所示。
表1治疗效果调查表
治愈 | 显效 | 有效 | 无效 | |
实验组 | 16 | 3 | 1 | 0 |
对照组 | 11 | 4 | 3 | 2 |
空白对照组 | 0 | 0 | 2 | 18 |
表2复发情况调查表
第3周 | 第6周 | 第9周 | |
实验组 | 0 | 0 | 1 |
对照组 | 2 | 2 | 3 |
由表1记载的内容可知,以实验组实验效果最优,其总有效率高达100%,治愈率高达80%,显著高于对照组的55%,这足以证明本发明得到的组合物具有优异的治疗湿疹的技术效果。而空白对照组也出现两例有效病例,可能是患者自身恢复情况较好。
由表2记载的内容可知,实验组在治疗后6周内,没有患者复发的情况,只在第9周出现1例患者复发,分析原因可能是患者解除到了过敏原导致的复发。这就说明了本发明得到的组合物在有效治疗湿疹的同时,可有效抑制湿疹的复发。而对照组在第3、6、9周都出现了患者复发的情况,说明传统的药物虽然可以有效治疗湿疹,但是防止湿疹复发的效果差。
以上所述仅是本发明的优选实施方式,应当指出,对于本技术领域的普通技术人员来说,在不脱离本发明原理的前提下,还可以做出若干改进和润饰,这些改进和润饰也应视为本发明的保护范围。
Claims (10)
1.一种治疗湿疹的中药组合物,其特征在于,由包括如下质量份数的组分制备而成:当归10~14份、川芎10~14份、黄连8~12份、地黄7~11份、牛蒡子6~10份、仙灵脾6~10份、龙胆草5~9份、枳实5~9份、牡丹皮4~8份和甘草4~8份。
2.根据权利要求1所述的一种治疗湿疹的中药组合物的制备方法,其特征在于,包括如下步骤:
(1)将当归、川芎、黄连、地黄、牛蒡子、仙灵脾、龙胆草、枳实、牡丹皮和甘草混合,粉碎得物料1;
(2)将所述物料1与水混合浸提,过滤得滤液1和滤渣1;
(3)将所述滤渣1与水混合进行一次煎煮,过滤得滤液2和滤渣2;
(4)将所述滤渣2与水混合进行二次煎煮,过滤得滤液3;
(5)将所述滤液1、滤液2和滤液3混合得治疗湿疹的中药组合物。
3.根据权利要求2所述的一种治疗湿疹的中药组合物的制备方法,其特征在于,步骤(1)所述粉碎后的物料1过40~60目筛,筛下物即为物料1。
4.根据权利要求2所述的一种治疗湿疹的中药组合物的制备方法,其特征在于,步骤(2)所述浸提的时间为1.5~2.5h。
5.根据权利要求3所述的一种治疗湿疹的中药组合物的制备方法,其特征在于,步骤(2)所述物料1和水的质量比为1∶3~5。
6.根据权利要求5所述的一种治疗湿疹的中药组合物的制备方法,其特征在于,步骤(2)所述水的温度为50~60℃。
7.根据权利要求2所述的一种治疗湿疹的中药组合物的制备方法,其特征在于,步骤(3)所述一次煎煮时间为2~4h。
8.根据权利要求2所述的一种治疗湿疹的中药组合物的制备方法,其特征在于,步骤(3)所述滤渣1与水的质量比为1∶4~6。
9.根据权利要求2所述的一种治疗湿疹的中药组合物的制备方法,其特征在于,步骤(4)所述二次煎煮时间为0.5~1.5h。
10.根据权利要求2所述的一种治疗湿疹的中药组合物的制备方法,其特征在于,步骤(4)所述滤渣2与水的质量比为1∶2~4。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310349615.4A CN116585389A (zh) | 2023-04-04 | 2023-04-04 | 一种治疗湿疹的中药组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310349615.4A CN116585389A (zh) | 2023-04-04 | 2023-04-04 | 一种治疗湿疹的中药组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116585389A true CN116585389A (zh) | 2023-08-15 |
Family
ID=87606912
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310349615.4A Pending CN116585389A (zh) | 2023-04-04 | 2023-04-04 | 一种治疗湿疹的中药组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116585389A (zh) |
-
2023
- 2023-04-04 CN CN202310349615.4A patent/CN116585389A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105412893A (zh) | 一种筋骨通喷剂及其制作方法 | |
CN107789484B (zh) | 一种治疗月经不调的中药组合物及其制备方法 | |
CN105920268B (zh) | 治疗鸡坏死性肠炎的中药组合物及其制备方法 | |
CN105079726A (zh) | 一种治疗痔疮的药物组合物及其制备方法 | |
CN104840695A (zh) | 一种用于治疗仔猪白痢的药物组合物及其制备方法 | |
CN107737288B (zh) | 一种治疗过敏性哮喘的中药组合物及其制备方法 | |
CN104984296A (zh) | 一种治疗女性更年期综合症的药物组合物及其制备方法 | |
CN116585389A (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
CN112316034A (zh) | 一种用于治疗慢性咽炎的外敷中药组合物及制备方法和应用 | |
CN105343847A (zh) | 一种含有艾叶的治疗湿疹的中药组合物及其制备方法 | |
CN111529632A (zh) | 一种用于治疗小儿鼻出血的中药配方及其制备方法 | |
CN105617322A (zh) | 一种治疗牛皮癣的中药组合物及其制备方法 | |
CN104173491A (zh) | 一种防治牛中暑的中草药提取物制剂及其制备方法 | |
US11944660B1 (en) | Topical traditional Chinese medicine (TCM) composition and topical preparation for cervical disease, and preparation methods thereof | |
CN108159347B (zh) | 用于治疗腹泻型肠易激综合征的中药组合物及其制备方法 | |
CN105770515A (zh) | 一种治疗前列腺炎的中药组合物及其制备方法 | |
CN105412392A (zh) | 一种治疗痔疮的中药组合物及其制备方法 | |
CN117771166A (zh) | 一种治疗靶向药物相关性皮疹的中药膏剂及其制备方法和应用 | |
CN105770552A (zh) | 一种含有艾叶的治疗前列腺炎的中药制剂及其制备方法 | |
CN105770637A (zh) | 治疗妇科炎症的药物组合物 | |
CN105169342A (zh) | 一种治疗湿疹的中药组合物及其制备方法 | |
CN104547945A (zh) | 一种治疗淋巴结核的中药制剂及其制备方法 | |
CN115089679A (zh) | 一种治疗股骨头坏死的中药配方 | |
CN112426484A (zh) | 治疗淋巴瘤的中药组合物 | |
CN113599470A (zh) | 一种治疗羊肠毒血症的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |